Areteia Reports Positive Phase III Results for Oral Dexpramipexole in Eosinophilic Asthma Areteia Therapeutics, Inc. announced today that its Phase III EXHALE-4 clinical trial has met key efficacy and safety endpoints for dexpramipexole, an investigational oral therapy being developed as…
Impulse Space, a U.S.-based leader in in-space transportation, and Infinite Orbits, a France-based company specializing in in-orbit services, have expanded their collaboration by signing a new multi-launch agreement. The deal will deliver multiple Infinite Orbits spacecraft to geostationary orbit (GEO)…
Ionis Pharmaceuticals, Inc. marked a major milestone today, celebrating the 10th anniversary of Surf Away+, its signature adaptive community event. What began as an initiative to provide people with spinal muscular atrophy (SMA) access to adaptive surfing has evolved into…
Orano Med, the oncology-focused subsidiary of the Orano group, has announced a significant milestone in the construction of its Advanced Thorium Extraction Facility (ATEF) in Bessines-sur-Gartempe, near Limoges, France. The project has reached the watertight or “dry-in” phase, meaning sealing…
ISG (Information Services Group), a global AI-focused technology research and advisory firm, has announced the winners of the third annual ISG Women in Digital Awards for the Asia Pacific region. The program, launched in the Americas in 2022 and expanded…
Vertex Scientists Honored with Prestigious Lasker~DeBakey Award for Transformational Advances in Cystic Fibrosis Vertex Pharmaceuticals Incorporated announced today that Dr. Paul Negulescu, Senior Vice President, has been named a recipient of the 2025 Lasker~DeBakey Clinical Medical Research Award. Dr. Negulescu…
Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company pioneering innovative cancer therapeutics, announced today it will host a virtual Key Opinion Leader (KOL) event on Thursday, September 18 at 5:00 p.m. ET / 2:00 p.m. PT. The event will spotlight interim…
Ferring Pharmaceuticals Co., Ltd. announced today that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has formally accepted the New Drug Application (NDA) for nadofaragene firadenovec, a novel non-replicating intravesical gene therapy developed for patients with high-risk, Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle…
Seaport Therapeutics a clinical-stage biopharmaceutical company developing next-generation neuropsychiatric medicines, announced that the first participant has been dosed in its Phase 1 clinical study of GlyphAgo™ (SPT-320 or Glyph Agomelatine). GlyphAgo is a novel “Glyphed” oral prodrug of agomelatine designed…
Merck, known as MSD outside of the United States and Canada, announced significant new findings from its Phase 3 STRIDE-13 clinical trial of CAPVAXIVE® (pneumococcal 21-valent conjugate vaccine). The results, presented at the 6th European Society of Clinical Microbiology and…
Westlake Chemical Partners LP (NYSE: WLKP) (the “Partnership”) today reported net income attributable to the Partnership in the second quarter of 2025 of $14.6 million, or $0.41 per limited partner unit, which was in line with second quarter 2024 net…
A large gathering of 2’215 shareholders followed the invitation to the 62nd Annual General Meeting of EMS-CHEMIE HOLDING AG at Domat/Ems on August 9, 2025. A total of 20’467’468 registered shares were represented, corresponding to 92.9% of all shares entitled to vote. The…